Science Explorer Back to mapMap
Discussion
Researcher · Bayer (United States) · United States

Scott D. Berkowitz

Scott D. Berkowitz publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine, on topics such as Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management and Antiplatelet Therapy and Cardiovascular Diseases.

ORCID 0000-0002-9428-4408 OpenAlex
World rank
#57,723
of 7,710,434 ranked researchers
Rank in United States
#22,271
of 1,627,098
Works
287
Citations
29k
Citations per work
101.8
h-index
70
i10-index 173Top 1.2% in Cardiology and Cardiovascular Medicine
Scott D. Berkowitz

What does Scott D. Berkowitz research?

Scott D. Berkowitz's work is mostly in Medicine (85%).

Health Sciences: 243 works · 84.7% of their workMedicine: 243 works · 84.7% of their workCardiology and Cardiovascular Medicine: 104 works · 36.2% of their workSurgery: 47 works · 16.4% of their workInternal Medicine: 38 works · 13.2% of their workPulmonary and Respiratory Medicine: 22 works · 7.8% of their workHematology: 22 works · 7.5% of their workEpidemiology: 10 works · 3.6% of their workEverything else: 44 works · 15.3% of their workTHEIR WORKScott D.Berkowitz287works
Health Sciences85%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine24384.7%
  2. Everything else4415.3%
  1. 1Cardiology and Cardiovascular Medicine36% of their works
  2. 2Surgery16% of their works
  3. 3Internal Medicine13% of their works
  4. 4Pulmonary and Respiratory Medicine8% of their works
  5. 5Hematology8% of their works
  6. 6Epidemiology4% of their works

Research topics

Which keywords describe Scott D. Berkowitz's research?

The keywords of their largest research topics: Guidelines, Risk Factors, Anticoagulant Therapy, Atrial Fibrillation, Diagnosis, Antithrombotic Therapy, Venous Thromboembolism and Revascularization.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Guidelines2263 topics
  2. Risk Factors1923 topics
  3. Anticoagulant Therapy1311 topic
  4. Atrial Fibrillation1311 topic
  5. Diagnosis1312 topics
  6. Antithrombotic Therapy1041 topic
  7. Venous Thromboembolism1041 topic
  8. Revascularization882 topics
  9. Aspirin661 topic
  10. Clopidogrel661 topic
  11. Angioplasty601 topic
  12. Peripheral Arterial Disease601 topic
  13. Thrombosis502 topics
  14. Acute Coronary Syndromes351 topic
  15. Myocardial Infarction351 topic
  16. Ischemic Stroke281 topic
  17. Thrombolysis281 topic
  18. Heparin-Induced Thrombocytopenia271 topic
  19. Vaccination271 topic
  20. Immune Thrombocytopenic Purpura231 topic
  21. Platelets231 topic

Where does Scott D. Berkowitz work?

Scott D. Berkowitz's main affiliation in the publication record is Bayer (United States), United States.

How many publications and citations does Scott D. Berkowitz have?

OpenAlex counts 287 works and 29,205 citations for Scott D. Berkowitz, an h-index of 70, ranking #57,723 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Scott D. Berkowitz. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.